Skip to main content
Premium Trial:

Request an Annual Quote

J&J Expands In Silico Hematology Research Project with Entelos

NEW YORK, July 7 (GenomeWeb News) - Entelos said yesterday that it has expanded a hematology research collaboration with Johnson & Johnson Pharmaceutical Research & Development that began a year and a half ago.


In the expanded program, Entelos will use its PhysioLab biosimulation technology to study the effect of anti-anemia therapy on patients with different types of anemia. Entelos said it will also use its platform to "explore the impact of patient variability, and provide guidance on optimization of anemia clinical trials." 


Entelos and J&JPRD began co-developing developing the Hematopoiesis PhysioLab in January 2004.


Financial terms for the expanded agreement were not provided.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.